TP53 and colorectal carcinoma: In both studies, we have observed a consistent differential distribution of the major haplotypes built on the four variants between cases and controls, suggesting that prevalent haplotypes within the TP53 gene may modulate both CRC and pancreatic cancer risk [27,28].